Dual-mobility total hip arthroplasty in patients younger than 55 years old: a systematic review
Archives of Orthopaedic and Trauma Surgery · 2023
DOI: 10.1007/s00402-023-04882-2 ↗Kurz gefasst
Systematische Übersicht in der Zeitschrift Archives of Orthopaedic and Trauma Surgery, 2023. Verfasst von Biagio Zampogna und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Orthopaedic and Trauma Surgery, Università Campus Bio-Medico Di Roma, Via Alvaro del Portillo, 21-00128, Rome, Italy. Hauptthemen laut MEDLINE: Arthroplasty, Replacement, Hip, Hip Prosthesis, Hip Dislocation, Joint Dislocations. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 24 Literaturangaben.
Themen: Mobilisation
Abstract (Originalsprache)
Total hip arthroplasty (THA) is regarded as one of the most successful and cost-effective orthopedic procedures. However, THA is a surgical procedure with potential intraoperative and postoperative risks. Dislocation is one of the common postoperative complications and remains one of the main indications for THA revision. The purpose of this systematic review was to evaluate the role and the outcomes of dual-mobility implant to prevent dislocation in patients younger than < 55 years in primary THA. In this systematic review, we included observational, prospective, and retrospective studies that evaluated the outcome and the complications of the dual-mobility cup in < 55-year-old patients. After applying exclusion criteria (femoral neck fractures or THA revision, case series, reviews, and meta-analyses), ten articles were included in the study. The overall number of participants in all the studies was 1530. The mean age of the participants was 50 years. The mean follow-up was 11.7 years. A total of 46 patients (2.7%) reported intraprosthetic dislocations, in which the polyethylene liner dissociates from the femoral head, while 4.8% of revision was due to aseptic loosening. The mean revision rate at twelve years was 11%. The mean value of Harris Hip Score increased from 50.9 pre-operatively to 91.6 after surgery. Dual mobility is a valid option for young patients with extended survivorship and low rates of instability and dislocation after primary THA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Orthopaedic and Trauma Surgery, Università Campus Bio-Medico Di Roma, Via Alvaro del Portillo, 21-00128, Rome, Italy.
- Research Unit of Orthopaedic and Trauma Surgery, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, 200-00128, Rome, Italy.
- Department of Orthopaedic and Trauma Surgery, Università Campus Bio-Medico Di Roma, Via Alvaro del Portillo, 21-00128, Rome, Italy. g.papalia@policlinicocampus.it.
- Research Unit of Orthopaedic and Trauma Surgery, Fondazione Policlinico Universitario Campus Bio-Medico, Via Alvaro del Portillo, 200-00128, Rome, Italy. g.papalia@policlinicocampus.it.
- Department of Clinical Science and Translational Medicine, Section of Orthopaedics and Traumatology, University of Rome "Tor Vergata", Rome, Italy.
Zitieren
APA
Zampogna, B., Papalia, G. F., Ferrini, A., Torre, G., Vorini, F., Diaz Balzani, L. A., Farsetti, P., & Papalia, R. (2023). Dual-mobility total hip arthroplasty in patients younger than 55 years old: a systematic review. Archives of Orthopaedic and Trauma Surgery. https://doi.org/10.1007/s00402-023-04882-2
Vancouver
Zampogna B, Papalia GF, Ferrini A, Torre G, Vorini F, Diaz Balzani LA, et al. Dual-mobility total hip arthroplasty in patients younger than 55 years old: a systematic review. Archives of Orthopaedic and Trauma Surgery. 2023. doi:10.1007/s00402-023-04882-2
BibTeX
@article{Zampogna2023,
author = {Zampogna, Biagio and Papalia, Giuseppe Francesco and Ferrini, Augusto and Torre, Guglielmo and Vorini, Ferruccio and Diaz Balzani, Lorenzo Alirio and Farsetti, Pasquale and Papalia, Rocco},
title = {Dual-mobility total hip arthroplasty in patients younger than 55 years old: a systematic review},
journal = {Archives of Orthopaedic and Trauma Surgery},
year = {2023},
doi = {10.1007/s00402-023-04882-2}
}
EUVIMED